BUY Krishna Institute of Medical Sciences Limited — Emkay Global

Entry₹742Inferred
Target₹850
Total upside +14.56%
Stop lossNot given
CMP₹725.2Just now
Active-2.26%+17.21%upside left 12 mo left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 1 Oct, 2:32 pm IST
11 supporting9 neutral6 opposing
Supports the BUY call (11)

4 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·1 Oct · today

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·30 Sept · yesterday

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·17 Sept · 2w ago

KIMS enters O&M agreement to manage 183-bed Trust Hospital in Kakinada, Andhra Pradesh

NewsCnbc-Tv18·10 Sept · 3w ago

(opens in new tab)

Krishna Institute of Medical Sciences Ltd entered into an Operations and Management Agreement with Sarvottam Health Care Private Limited.

BSE · Company Update·10 Sept · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.